Cancer Research SABCS  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 11811, December 15, 2007. doi: 10.1158/0008-5472.CAN-07-0722
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shareef, M. M.
Right arrow Articles by Ahmed, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shareef, M. M.
Right arrow Articles by Ahmed, M. M.

Experimental Therapeutics, Molecular Targets, and Chemical Biology

Role of Tumor Necrosis Factor-{alpha} and TRAIL in High-Dose Radiation–Induced Bystander Signaling in Lung Adenocarcinoma

Mohammed M. Shareef1, Nuan Cui2, Ravshan Burikhanov2, Seema Gupta1, Sabapathi Satishkumar2, Shahin Shajahan2, Mohammed Mohiuddin3, Vivek M. Rangnekar2 and Mansoor M. Ahmed1,4

1 Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania; 2 Department of Radiation Medicine, University of Kentucky, Lexington, Kentucky; 3 Geisinger-Fox Chase Cancer Center, Geisinger Clinic, Wilkes-Barre, Pennsylvania; and 4 Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania

Requests for reprints: Mansoor M. Ahmed, Weis Center for Research, Geisinger Clinic, Office 121A, 100 N. Academy Avenue, Danville, PA 17822-2616. Phone: 570-214-3972 or 570-271-8660; Fax: 570-214-9861; E-mail: mmahmed{at}geisinger.edu.

In the present study, ionizing radiation (IR)–induced bystander effects were investigated in two lung cancer cell lines. A549 cells were found to be more resistant to radiation-conditioned medium (RCM) obtained from A549 cells when compared with the H460 exposed to RCM procured from H460 cells. Significant release of tumor necrosis factor-{alpha} (TNF-{alpha}) was observed in A549 cells after IR/RCM exposure, and the survival was reversed with neutralizing antibody against TNF-{alpha}. In H460 cells, significant release of TNF-related apoptosis-inducing ligand (TRAIL), but not TNF-{alpha}, was observed in response to IR, RCM exposure, or RCM + 2Gy, and neutralizing antibody against TRAIL diminished clonogenic inhibition. Mechanistically, TNF-{alpha} present in RCM of A549 was found to mediate nuclear factor-{kappa}B (NF-{kappa}B) translocation to nucleus, whereas the soluble TRAIL present in RCM of H460 cells mobilized the nuclear translocation of PAR-4 (a proapoptotic protein). Analysis of IR-inducible early growth response-1 (EGR-1) function showed that EGR-1 was functional in A549 cells but not in H460 cells. A significant decrease in RCM-mediated apoptosis was observed in both A549 cells stably expressing small interfering RNA EGR-1 and EGR-1–/– mouse embryonic fibroblast cells. Thus, the high-dose IR-induced bystander responses in A549 may be dependent on the EGR-1 function and its target gene TNF-{alpha}. These findings show that the reduced bystander response in A549 cells is due to activation of NF-{kappa}B signaling by TNF-{alpha}, whereas enhanced response to IR-induced bystander signaling in H460 cells was due to release of TRAIL associated with nuclear translocation of PAR-4. [Cancer Res 2007;67(24):11811–20]




This article has been cited by other articles:


Home page
CarcinogenesisHome page
A. Luce, A. Courtin, C. Levalois, S. Altmeyer-Morel, P.-H. Romeo, S. Chevillard, and J. Lebeau
Death receptor pathways mediate targeted and non-targeted effects of ionizing radiations in breast cancer cells
Carcinogenesis, March 1, 2009; 30(3): 432 - 439.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
T. T. Koll, S. S. Feis, M. H. Wright, M. M. Teniola, M. M. Richardson, A. I. Robles, J. Bradsher, J. Capala, and L. Varticovski
HSP90 inhibitor, DMAG, synergizes with radiation of lung cancer cells by interfering with base excision and ATM-mediated DNA repair
Mol. Cancer Ther., July 1, 2008; 7(7): 1985 - 1992.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.